Join an exclusive virtual visit of Cynbiose’s Infrastructure

Cynbiose invites you to experience an immersive journey through a virtual visit of its unique infrastructure in Europe. The second session of this exclusive event will take place :

• Thursday, March 20, 20225, at 3.00 pm (UTC +1)

Join us for this virtual tour

This 45-minutes virtual tour is the perfect opportunity to understand the role of our infrastructure in supporting our company as a CRO specializing in preclinical studies involving non-human primates (NHP) and our expertise in various therapeutic areas, including:

• Infectious respiratory and non-respiratory diseases
• Central nervous System (CNS)
• GMO studies
• Toxicology studies

Through inspiring testimonials from clients and partners, you will see how Cynbiose continues to innovate and meet the specific needs of the biotech and pharmaceutical industries with its unique infrastructure.

Programm of our virtual visit:

• Introduction by our CEO, Hugues CONTAMIN
• Virtual visit of our infrastructure
• Insights from our CSO, Joachim CONFAIS
• Testimonials from clients and partners
  • Erwan BÉZARD, CEO of MOTAC Neuroscience
  • Jean-Guillaume LAFAY, former CEO of Mablink Bioscience, Chairman and Founder of Norfoalk
• Q&A Session

Why should you join our virtual visit?

The Xpansion Project, launched in 2021, enabled Cynbiose to construct a cutting-edge facility to support its growth. Now fully operational, this unique infrastructure offers remarkable agility, allowing us to conduct preclinical studies in a secure and controlled environment.

This virtual visit will give you valuable insights into our expertise and demonstrate how our infrastructure can add value to your preclinical research projects.

Where ? Online

When?

• Thursday, March 20, 20225, at 3.00 pm (UTC +1)

Join us for this unique event and step into our company, where innovation meets scientific excellence!

Watch our Teaser now:

Contact us :

Erwan CORCUFF
Chief Business Officer
erwan.corcuff@cynbiose.com